Monitoring of BCR-ABL levels in chronic myeloid leukemia patients treated with imatinib in the chronic phase - the importance of a major molecular response

Documenti analoghi

• Concomitant essential thrombocythemia with JAK2 V617F mutation in a patient with chronic myeloid leukemia with major molecular response with imatinib and long-term follow-up
  di: PAGNANO, KATIA BORGIA BARBOSA, et al.
  Pubblicazione: (2016)
• Evaluation of anemia after long-term treatment with imatinib in chronic myeloid leukemia patients in chronic phase
  di: Moura, Muriel Silva, et al.
  Pubblicazione: (2019)
• Expression of p190 BCR-ABL fusion gene in a patient with chronic myeloid leukemia Expressão do rearranjo gênico BCR-ABL com ponto de quebra na região menor do gene BCR em um paciente com leucemia mielóide crônica
  di: P. V. B. Carvalho, et al.
  Pubblicazione: (2003-01-01)
• Management of chronic myeloid leukemia during pregnancy: a retrospective analysis at a single center
  di: Moura, Ariella Cássia de, et al.
  Pubblicazione: (2019)
• BCR-ABL1 level monitoring in chronic myeloid leukemia by real time polymerase chain reaction in Brazil – not so real()
  di: Pagnano, Katia Borgia Barbosa
  Pubblicazione: (2017)